Category Archives: LABD-25-11

Margin Debt … $1-Trillion

September 18, 2025 By in $SPSIBI, Biotech, DIA, IBB, IWM, IYR, LABD, LABD-25-11, Positions, QQQ, S&P, S&P 500, SPBIO, SPY, Up-Thrust, Wyckoff, XBI, XLF, ZeroHedge

When it Implodes

Is the bell ringing?

Is this it?

In the pre-market, SPY, DIA, XLF, QQQs, all-time highs.

Meanwhile, beneath the surface, it’s getting a bit ‘uncomfortable’.

One Trillion in margin debt as reported here and here.

The Ones To Watch

While all eyes are focused on the leaders (above), at least three markets are not participating:

Real Estate, IYR, Russell IWM, biotech, IBB, and XBI.

From a Wyckoff perspective, for short candidates, these are the ones to watch (not advice, not a recommendation).

Biotech, XBI

As stated in the prior update, XBI may have formed a triple top within and ‘up-thrust’, link here.

The obvious areas to watch for today’s session, are yesterday’s high and low.

A new high puts the up-thrust into question; new low, adds (a small) confirmation to reversal.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Rate Cut … Now, What?

September 17, 2025 By in Biotech, Federal Reserve, Interest Rates, LABD, LABD-25-11, Michael Bordenaro, Positions, ShadowStats, SPBIO, XBI

Think, ‘Outside The Herd’

Michael Bordenaro, spells out the current jobs situation from a ‘boots on the ground’ perspective, link here.

From the video and comments, the agreement seems to be, unemployment is much higher than 5%.

Of course, if one is interested, more accurate job numbers (and inflation numbers) are at this link.

Separately, it appears that biotech XBI, has made a triple-top (not advice, not a recommendation).

More on that, later.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Breakout or Breakdown … Biotech

September 16, 2025 By in $SPSIBI, Federal Reserve, Interest Rates, LABD, LABD-25-11, MyStrategicForecast, Positions, QQQ, SPBIO, SPY, Up-Thrust, XBI 2 Comments

‘Winds of Change‘

The last update said, XBI presented the ‘best (index) short opportunity’ (not advice, not a recommendation).

Is that still true?

With the SPY and Qs, still grinding higher, XBI is absent, having topped four days ago.

It’s not necessarily the top per se, but the XBI location in the overall market.

While the major indices are just now reaching all-time highs, biotech XBI, posted all-time highs years ago.

Four and a half years, to be more precise.

Biotech XBI, Daily

Today’s action can be considered as a ‘test’ of the attempted (possibly failed) breakout.

There’s ‘evidence of a struggle’ and XBI is not (at this time) moving higher.

Adding to that, we have what’s been referred to as ‘Kabuki Theater‘ coming up at 2:00 p.m., EST, tomorrow).

Let’s see what happens next.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279